|
|
| MRD / Regn No. |
: THBC\23-24\01837 |
Date |
: 09/06/2026 |
| Patient Name |
: Vidhya Srinivas |
Age & Gender |
: 48 Yrs. / Female |
| Contact No. |
: 9920020114 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (16/Mar/2016) | |
|
Subjective |
: |
TYPE 2 DM 7-8 YEARS,DYSLIPIDEMIA,? STROKE IN 2022 - NEUROLOGIST,RESTARTED WALK 4-5K/MTH,EATING HEALTHY MOST OF THE TIME / 2 MEALS A DAY,FEELING WELL WITH WEGOVY - 7-8 KGS - 102 TO 94 KGS SO FAR,STOP GALVUS MET |
|
Objective |
: |
JUNE 2026,HB-14.8,HBA1C-8.3,TC-188/TG-187/LDL-107/HDL-60.3,CR-0.63,AST-24/ALT-27,ACR-< 30,FT3-.75/FT4-1.23/TSH-3.547,CORTISOL MOR-17.69,VIT B1-493,VIT D3-53.4,AMYLASE-115,LIPASE-32 |
|
Plan |
: |
RETINA TO BE TESTED IN NEXT 2-3 WEEKS |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
UPRISE D3 60,000 UNITS |
ORAL |
ONCE IN 15 DAYS |
ANYTIME OF DAY
|
3 MTHS |
|
|
2 |
TABLET DEXLANSOPRAZOLE DDR 60 MG |
ORAL |
1-0-0 |
BBF
|
30 DAYS |
|
|
3 |
DAPAVEL M 10+500 MG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
4 |
GLIMISAVE M2 |
ORAL |
1-0-1 |
BBF / BD
|
2 MTHS |
|
|
5 |
INJ WEGOVY 0.25 MG |
SC |
0.25 MG |
ANYTIME OF DAY
|
2 MORE DOSES |
|
|
6 |
INJ WEGOVY 0.5 MG |
SC |
0.5 MG |
WEEKLY
|
4 WEEKS |
|
|
7 |
INJ WEGOVY 1 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
8 |
AZULIX MV 2/0.2 MG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
9 |
TABLET EMPAGLIFLOZIN JARDIANCE 25 MG |
ORAL |
1-0-0 |
AFTER BFK
|
3 MTHS |
|
|
10 |
BEMALIP 180 MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
11 |
ROSEDAY CV 20 / 75 MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
12 |
AZULIX MV 1 / 0.2 MG |
ORAL |
0-0-1 |
BEFORE DINNER
|
3 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 09/Sep/2026 |
| Tests Suggested For Next Visit |
: HBA1C / FBS / PPBS > 3 MTHS |
| |
|
| |
|
|